Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070131710> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2070131710 endingPage "204" @default.
- W2070131710 startingPage "199" @default.
- W2070131710 abstract "The “atypical” antipsychotics are grouped together by what they are not (i.e., not dopamine2 selective antagonists like haloperidol). While sharing that characteristic, these agents differ substantially in pharmacokinetics and pharmacodynamics. This column, the first in a series on these agents, reviews the bioavailability and half-life of the 10 newer “atypical” antipsychotics, including the most recently marketed members of this class (asenapine, iloperidone, and lurasidone). Drugs with high oral bioavailability are generally less susceptible to diet or drug-drug interactions affecting first pass metabolism. The converse is true for drugs with lower oral bioavailability (e.g., they may have a food effect in which oral bioavailability is decreased in the fasted versus fed state). The half-life of an antipsychotic agent in large measure determines whether it can be safely and effectively administered once a day, at least in an immediate release formulation. Pharmacokinetic differences among atypical antipsychotics can explain why some individuals may not respond to the usually effective dose of a drug, while others may be especially sensitive to its dose-dependent adverse effects. An understanding of pharmacokinetic differences among the atypical antipsychotics can help clinicians optimize drug selection and dose for specific patients under specific treatment conditions. Subsequent columns in this series on atypical antipsychotics will discuss their metabolism, including the principal enzyme(s) mediating each drug’s clearance, effects of co-administration of substantial CYP enzyme inhibitors, effect of hepatic and renal impairment, and the substantial and clinically important pharmacodynamic differences among these agents. (Journal of Psychiatric Practice 2012;18:199–204)" @default.
- W2070131710 created "2016-06-24" @default.
- W2070131710 creator A5089332899 @default.
- W2070131710 date "2012-05-01" @default.
- W2070131710 modified "2023-09-30" @default.
- W2070131710 title "Clinically Important Differences in the Pharmacokinetics of the Ten Newer “Atypical” Antipsychotics" @default.
- W2070131710 cites W1981617136 @default.
- W2070131710 cites W2019658757 @default.
- W2070131710 cites W2077283753 @default.
- W2070131710 cites W2089934994 @default.
- W2070131710 cites W59829318 @default.
- W2070131710 doi "https://doi.org/10.1097/01.pra.0000415076.28497.8e" @default.
- W2070131710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22617084" @default.
- W2070131710 hasPublicationYear "2012" @default.
- W2070131710 type Work @default.
- W2070131710 sameAs 2070131710 @default.
- W2070131710 citedByCount "15" @default.
- W2070131710 countsByYear W20701317102012 @default.
- W2070131710 countsByYear W20701317102013 @default.
- W2070131710 countsByYear W20701317102014 @default.
- W2070131710 countsByYear W20701317102016 @default.
- W2070131710 countsByYear W20701317102017 @default.
- W2070131710 countsByYear W20701317102018 @default.
- W2070131710 countsByYear W20701317102020 @default.
- W2070131710 countsByYear W20701317102022 @default.
- W2070131710 crossrefType "journal-article" @default.
- W2070131710 hasAuthorship W2070131710A5089332899 @default.
- W2070131710 hasConcept C111113717 @default.
- W2070131710 hasConcept C112705442 @default.
- W2070131710 hasConcept C118552586 @default.
- W2070131710 hasConcept C181389837 @default.
- W2070131710 hasConcept C2776412080 @default.
- W2070131710 hasConcept C2776701107 @default.
- W2070131710 hasConcept C2776921671 @default.
- W2070131710 hasConcept C2779626651 @default.
- W2070131710 hasConcept C2780035454 @default.
- W2070131710 hasConcept C2780494398 @default.
- W2070131710 hasConcept C71924100 @default.
- W2070131710 hasConcept C98274493 @default.
- W2070131710 hasConceptScore W2070131710C111113717 @default.
- W2070131710 hasConceptScore W2070131710C112705442 @default.
- W2070131710 hasConceptScore W2070131710C118552586 @default.
- W2070131710 hasConceptScore W2070131710C181389837 @default.
- W2070131710 hasConceptScore W2070131710C2776412080 @default.
- W2070131710 hasConceptScore W2070131710C2776701107 @default.
- W2070131710 hasConceptScore W2070131710C2776921671 @default.
- W2070131710 hasConceptScore W2070131710C2779626651 @default.
- W2070131710 hasConceptScore W2070131710C2780035454 @default.
- W2070131710 hasConceptScore W2070131710C2780494398 @default.
- W2070131710 hasConceptScore W2070131710C71924100 @default.
- W2070131710 hasConceptScore W2070131710C98274493 @default.
- W2070131710 hasIssue "3" @default.
- W2070131710 hasLocation W20701317101 @default.
- W2070131710 hasLocation W20701317102 @default.
- W2070131710 hasOpenAccess W2070131710 @default.
- W2070131710 hasPrimaryLocation W20701317101 @default.
- W2070131710 hasRelatedWork W1978032370 @default.
- W2070131710 hasRelatedWork W1979757582 @default.
- W2070131710 hasRelatedWork W2007204603 @default.
- W2070131710 hasRelatedWork W2022808342 @default.
- W2070131710 hasRelatedWork W2080955156 @default.
- W2070131710 hasRelatedWork W2316454641 @default.
- W2070131710 hasRelatedWork W2332367370 @default.
- W2070131710 hasRelatedWork W2397725669 @default.
- W2070131710 hasRelatedWork W2400461952 @default.
- W2070131710 hasRelatedWork W79555446 @default.
- W2070131710 hasVolume "18" @default.
- W2070131710 isParatext "false" @default.
- W2070131710 isRetracted "false" @default.
- W2070131710 magId "2070131710" @default.
- W2070131710 workType "article" @default.